Clinical Trials Sponsored by Yingqi Xing

Total 1527 results

Yingqi Xing

Completed

Registry of Right-to-left Shunt Detection by Contrast-enhanced Transcranial Doppler in Chinese Population

Migraine | Cerebral Infarction | Right-to-left Shunt

China
yin ying zhao

Completed

Silicone Tube for the Surgical Treatment of Glaucoma

Glaucoma, Open-Angle
yin ying zhao

Completed

Inflammatory Cytokines in Congenital Cataract After Lensectomy and Anterior Vitrectomy

Congenital Cataract

China
yin ying zhao

Completed

Clinical Characteristics in Congenital Cataract Eyes

Congenital Cataract
Ling-Ying Wu

Not yet recruiting

Real-world Study of Niraparib Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (RENI-1)

Epithelial Ovarian Cancer
Chen Ying

Enrolling by invitation

Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis

Sepsis

China
yin ying zhao

Completed

Effects of 23-gauge Lensecotomy Combined With Anterior Vitrectomy on Macular in Children With Congenital Cataract

Congenital Cataract | Macular

China
yin ying zhao

Completed

Effect of Phacoemulsification on Ocular Blood Flow in Human

Hypertension | Diabetes | Cataract

China
yin ying zhao

Completed

The Influences Of Anterior Capsule Polishing On Anterior Capsular Changes and Intraocular Lenses Stability of Super High Myopic Eyes

Myopia, High, With Cataract and Anterior Capsule Polished
Ying-Jie Ji

Completed

Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B

Hepatitis B, Chronic

China
Han Ying

Recruiting

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis

Primary Biliary Cholangitis

China
Tsung-Ying Li

Recruiting

Vitamin D Deficiency and Body Composition in the Patients With Hemophilia

Hemophilia | Vitamin D Deficiency | Body Composition | Sarcopenia | Osteoporosis | Hemophilic Arthropathy

Taiwan
Ying Liu
Avanos Medical

Recruiting

Intraperitoneal Infusion of Analgesic for Postoperative Pain Management (ON-Q)

Pain, Postoperative | Hysterectomy | Narcotic Use | Gynecologic Surgical Procedures

United States
ying cheng

Completed

Evaluate EGFR Mutation Status and Impact Factors in North China

Non-Small Cell Lung Cancer
Sun Ying-Shi

Active, not recruiting

Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI

Rectal Neoplasms

China
Zhang Ying Qian

Unknown

Efficacy Study of Nicorandil on Neointima

Diabetes Mellitus | Angina, Unstable

China
Sun Ying-Shi

Completed

Predicting Pathological Complete Response of Rectal Cancer With Magnetic Resonance(MR) Radiomics

Locally Advanced Rectal Cancer

China
Ying Xiao

Unknown

Influence of Profound Muscle Relaxation on Muscle Trauma and Postoperative Pulmonary Function

Muscle Trauma | Profound Muscle Relaxation | Postoperative Analgesic Demand | Postoperative Pulmonary Function

China
Ying Wang

Recruiting

CD7 CAR-T for Patients With r/r CD7+ Hematologic Malignancies

Hematological Malignancies

China
Ying An, MD

Completed

Buffered Local Anesthetic

Dental Pain

United States
Ying Lin

Recruiting

Neoadjuvant Camrelizumab and Fluzoparib and Nab-paclitaxel in Early Breast Cancer With HRR Gene Mutation (IMPARP)

Her-2 Negative Breast Cancer | HRR Gene Mutation

China
LI XIN-XIANG

Not yet recruiting

A Combination Therapy Including Anti-PD-1 Immunotherapy in Rectal Cancer With Refractory Distal Metastasis (Miracle-2)

Advanced Rectal Cancer | Distal Metastasis

China
LI XIN-XIANG

Completed

Electric Tubular Anastomosis in Rectal Cancer

Rectal Cancer | Anastomosis

China
LI XIN-XIANG

Recruiting

Carbon Nanoparticles vs Indocyanine Green

Number of Lymph Node Retrieved

China
LI XIN-XIANG

Not yet recruiting

Laparoscopic Surgery for T4 Tumor of the Colon Cancer

Colonic Neoplasms
LI XIN-XIANG

Not yet recruiting

Second Primary Cancer and Early-onset Colorectal Cancer

Colorectal Cancer | Second Primary Cancer
LI XIN-XIANG

Recruiting

Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

Rectal Neoplasms

China
LI XIN-XIANG

Recruiting

Laparoscopic Surgery for T4 Tumor of the Colon Cancer (LST4C Trial)

Colonic Neoplasms

China
Shanghai YingLi Pharmaceutical Co. Ltd.
Yingli Pharma US, Inc

Recruiting

YL-13027 in Patients With Advanced Solid Tumors

Solid Tumor

United States
Shanghai YingLi Pharmaceutical Co. Ltd.
Yingli Pharma US, Inc

Recruiting

A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C Mutation

Advanced Solid Tumor

United States
Shanghai Jun Pai Ying Shi Therapeutics Co., Ltd.
Sponsor GmbH

Recruiting

A Clinical Study of IMP4297 Capsule (JS109) Combined With Irinotecan in the Treatment of Advanced Malignant Solid Tumors

Advanced Solid Tumors

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Recruiting

A Study of YL-17231 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Recruiting

A Phase II Study of Linperlisib (YY-20394) in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma

Peripheral T/NK Cell Lymphoma (R/R PTCL)

United States
Shanghai YingLi Pharmaceutical Co. Ltd.

Not yet recruiting

A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Thymic Cancer

Effectiveness，Safety，Thymic Cancer
Shanghai YingLi Pharmaceutical Co. Ltd.

Unknown

YY-20394 、GEMOX Treatment Diffuse Large B-cell Lymphoma Single Arm, Open, Multicentrized Phase 1b/2 Clinical Trial

Diffuse Large B Cell Lymphoma
Shanghai YingLi Pharmaceutical Co. Ltd.

Unknown

A Study of YY-20394 in Participants With Relapsed/Refractory Follicular Non-Hodgkin's Lymphoma

Lymphoma, Follicular

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Unknown

A Phase I Study of YY-20394 in Patients With B Cell Hematologic Malignancies

B-cell Chronic Lymphocytic Leukemia | B-cell Lymphoma Recurrent

China
Ying Wang

Recruiting

The Establishment of a Survival Prediction Model for ER Positive / HER-2 Negative Advanced Breast Cancer

Breast Cancer

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Not yet recruiting

A National Multicenter, Real-world Study of Linperlisib in the Treatment of Lymphoma

Indolent B-cell Lymphoma
Shanghai YingLi Pharmaceutical Co. Ltd.

Not yet recruiting

A Study of HY-0102 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Recruiting

A Phase 1b/2 Study of YL-13027 Combined With Sintilimab in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Not yet recruiting

A Study of Linperlisib Combination With Camrelizumab in Patients With Solid Tumor

Advanced Solid Tumor
Shanghai YingLi Pharmaceutical Co. Ltd.

Enrolling by invitation

Phase I Clinical Study of YL-15293 in Patients With Advanced Solid Tumor With KRAS Mutation

Advanced Solid Tumor

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Unknown

A Phase Ib Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

Relapsed or Refractory Peripheral T-Cell Lymphoma

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Unknown

A Phase I Study of YY-20394 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Ying Gao
Beijing Chaoyang Integrative Medicine Rescue and First Aid Hospital

Recruiting

Analyzing the Pharmacodynamic Substances and the Effects of Xingnaojing for Mild-to-Severe Acute Ischemic Stroke (PUBLISH)

Ischemic Stroke, Acute

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Not yet recruiting

Pan-RAS Inhibitor YL-17231 in Patients With Advanced Solid Tumors Harboring Mutations in KRAS, HRAS, or NRAS

Advanced Solid Tumors

United States
Shanghai YingLi Pharmaceutical Co. Ltd.

Not yet recruiting

A Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma

PTCL
Shanghai YingLi Pharmaceutical Co. Ltd.

Recruiting

First in Human Dose Escalation Study of YL-13027 in Subjects With Advanced Stage Solid Tumors

Advanced Solid Tumors

China
Shanghai YingLi Pharmaceutical Co. Ltd.

Unknown

A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular Lymphoma

Follicular Lymphoma

3

Subscribe